Advertisement
Screener

EyePoint, Inc. (EYPT) Increase (Decrease) in Inventories

2.8 / 5 stars · 68/120 Roast Me

EyePoint, Inc. Increase (Decrease) in Inventories

EyePoint, Inc. (EYPT) reported Increase (Decrease) in Inventories of $69.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05

  • EyePoint, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $632.00K, a 15.12% increase year-over-year.
  • EyePoint, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$563.00K.
  • EyePoint, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$297.00K.
  • EyePoint, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$568.00K.
  • EyePoint, Inc. increase (decrease) in inventories for fiscal 2025 was -$492.00K.
  • EyePoint, Inc. increase (decrease) in inventories for fiscal 2024 was -$1.60M, a 203.03% decline from fiscal 2023.
  • EyePoint, Inc. increase (decrease) in inventories for fiscal 2023 was $1.55M, a 104.34% increase from fiscal 2022.
  • EyePoint, Inc. increase (decrease) in inventories for fiscal 2022 was $760.00K.
Period endIncrease (Decrease) in Inventories 3 monthIncrease (Decrease) in Inventories 6 monthIncrease (Decrease) in Inventories 9 monthIncrease (Decrease) in Inventories 12 month
2026-06-30$632.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$69.00K
10-Q · filed 2026-08-05
-$228.00K
derived: sum of 3 quarters · filed 2026-08-05
-$796.00K
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$563.00K
10-Q · filed 2026-05-07
-$860.00K
derived: sum of 2 quarters · filed 2026-05-07
-$1.43M
derived: sum of 3 quarters · filed 2026-05-07
-$879.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$297.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
-$865.00K
derived: sum of 2 quarters · filed 2026-03-05
-$316.00K
derived: sum of 3 quarters · filed 2026-08-05
-$492.00K
10-K · filed 2026-03-05
2025-09-30-$568.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$19.00K
derived: sum of 2 quarters · filed 2026-08-05
-$195.00K
10-Q · filed 2025-11-06
-$697.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$549.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$373.00K
10-Q · filed 2026-08-05
-$129.00K
derived: sum of 3 quarters · filed 2026-08-05
-$994.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$176.00K
10-Q · filed 2026-05-07
-$678.00K
derived: sum of 2 quarters · filed 2026-05-07
-$1.54M
derived: sum of 3 quarters · filed 2026-05-07
-$2.13M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$502.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
-$1.37M
derived: sum of 2 quarters · filed 2026-03-05
-$1.95M
derived: sum of 3 quarters · filed 2026-03-05
-$1.60M
10-K · filed 2026-03-05
2024-09-30-$865.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$1.45M
derived: sum of 2 quarters · filed 2025-11-06
-$1.10M
10-Q · filed 2025-11-06
-$1.77M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$584.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$233.00K
10-Q · filed 2025-08-07
-$904.00K
derived: sum of 3 quarters · filed 2025-08-07
-$589.00K
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$351.00K
10-Q · filed 2025-05-08
-$320.00K
derived: sum of 2 quarters · filed 2025-05-08
-$5.00K
derived: sum of 3 quarters · filed 2025-05-08
$719.00K
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31-$671.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
-$356.00K
derived: sum of 2 quarters · filed 2025-03-06
$368.00K
derived: sum of 3 quarters · filed 2025-03-06
$1.55M
10-K · filed 2025-03-06
2023-09-30$315.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$1.04M
derived: sum of 2 quarters · filed 2024-11-07
$2.22M
10-Q · filed 2024-11-07
$3.07M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$724.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$1.91M
10-Q · filed 2024-08-08
$2.75M
derived: sum of 3 quarters · filed 2024-08-08
$3.03M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$1.19M
10-Q · filed 2024-05-09
$2.03M
derived: sum of 2 quarters · filed 2024-05-09
$2.31M
derived: sum of 3 quarters · filed 2024-05-09
$2.23M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$845.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
$1.12M
derived: sum of 2 quarters · filed 2024-03-08
$1.04M
derived: sum of 3 quarters · filed 2024-03-08
$760.00K
10-K · filed 2024-03-08
2022-09-30$277.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$195.00K
derived: sum of 2 quarters · filed 2023-11-03
-$85.00K
10-Q · filed 2023-11-03
-$665.00K
derived: sum of 4 quarters · filed 2023-11-03
2022-06-30-$82.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
-$362.00K
10-Q · filed 2023-08-04
-$942.00K
derived: sum of 3 quarters · filed 2023-08-04
-$1.75M
derived: sum of 4 quarters · filed 2023-08-04
2022-03-31-$280.00K
10-Q · filed 2023-05-04
-$860.00K
derived: sum of 2 quarters · filed 2023-05-04
-$1.67M
derived: sum of 3 quarters · filed 2023-05-04
-$1.88M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31-$580.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10
-$1.39M
derived: sum of 2 quarters · filed 2023-03-10
-$1.59M
derived: sum of 3 quarters · filed 2023-03-10
-$1.35M
10-K · filed 2023-03-10
2021-09-30-$810.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
-$1.01M
derived: sum of 2 quarters · filed 2022-11-04
-$767.00K
10-Q · filed 2022-11-04
$930.00K
derived: sum of 4 quarters · filed 2022-11-04
2021-06-30-$205.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
$43.00K
10-Q · filed 2022-08-05
$1.74M
derived: sum of 3 quarters · filed 2022-08-05
$1.61M
derived: sum of 4 quarters · filed 2022-08-05
2021-03-31$248.00K
10-Q · filed 2022-05-06
$1.95M
derived: sum of 2 quarters · filed 2022-05-06
$1.81M
derived: sum of 3 quarters · filed 2022-05-06
$2.23M
derived: sum of 4 quarters · filed 2022-05-06
2020-12-31$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14
$1.56M
derived: sum of 2 quarters · filed 2022-03-14
$1.98M
derived: sum of 3 quarters · filed 2022-03-14
$3.20M
10-K · filed 2022-03-14
2020-09-30-$132.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$282.00K
derived: sum of 2 quarters · filed 2021-11-05
$1.50M
10-Q · filed 2021-11-05
$1.08M
derived: sum of 4 quarters · filed 2021-11-05
2020-06-30$414.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$1.64M
10-Q · filed 2021-08-06
$1.21M
derived: sum of 3 quarters · filed 2021-08-06
$2.10M
derived: sum of 4 quarters · filed 2021-08-06
2020-03-31$1.22M
10-Q · filed 2021-05-05
$800.00K
derived: sum of 2 quarters · filed 2021-05-05
$1.69M
derived: sum of 3 quarters · filed 2021-05-05
$2.47M
derived: sum of 4 quarters · filed 2021-05-05
2019-12-31-$421.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$467.00K
derived: sum of 2 quarters · filed 2021-03-12
$1.25M
derived: sum of 3 quarters · filed 2021-03-12
$1.86M
10-K · filed 2021-03-12
2019-09-30$888.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$1.67M
derived: sum of 2 quarters · filed 2020-11-06
$2.28M
10-Q · filed 2020-11-06
2019-06-30$785.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$1.39M
10-Q · filed 2020-08-05
2019-03-31$607.00K
10-Q · filed 2020-05-08
2018-12-31$279.00K
10-K · filed 2020-03-16
2018-06-30$0.00
10-KT · filed 2019-03-18
2017-06-30$0.00
10-KT · filed 2019-03-18
2016-06-30$0.00
10-KT · filed 2019-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
Quanterix Corp (QTRX)United States$0.150B-1.65
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15